跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUNLENCA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SUNLENCA
Authorized
STANDARD
SUNLENCA
gilead sciences canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
322824ea452ab99b
Company
gilead sciences canada inc
Type
Standard
Approval Details
Approval Id
322824ea452ab99b
Drug Approval Canada Name
SUNLENCA
Product Name
SUNLENCA
Status
Marketed
Status Date
2023-03-15
Original Market Date
2023-03-15
Din
02532468
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.08.92
Atc Original
J05AX31 LENACAPAVIR
Atc Name
j 05 ax 31
Aig Number
0164221001
Company Name
gilead sciences canada inc
Company Address
400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2
Active Ingredients
LENACAPAVIR (LENACAPAVIR SODIUM)
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
322824ea452ab99b
Type
Standard
Back to Health Canada Approvals